rabeximod (ROB 803) / Cyxone 
Welcome,         Profile    Billing    Logout  
 0 Diseases   2 Trials   2 Trials   187 News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rabeximod (ROB 803) / Cyxone
2020-004571-41: A Randomized, Placebo Controlled, Double Blind Study to Evaluate the Safety and Efficacy of Rabeximod Compared to Standard of Care in Patients With Moderate Coronavirus Disease (COVID-19)

Ongoing
2
300
Europe
Rabeximod, Capsule, hard
Cyxone AB, Cyxone AB
Coronavirus Disease (COVID-19), Coronavirus Disease (COVID-19), Diseases [C] - Respiratory Tract Diseases [C08]
 
 
2021-006665-38: A study to evaluate the possible side and the efficacy of orally administered Rabeximod when taken in combination with methotrexate compared with Methotrexate only in patients with active, moderate to severe rheumatoid arthritis with inadequate response to methotrexate

Ongoing
2
160
Europe
Rabeximod, OXY-001, Capsule
Cyxone AB, Cyxone AB
Active, moderate to severe rheumatoid arthritis with inadequate response to methotrexate, Active rheumatoid arthritis which is not adequately responding to methotrexate, Diseases [C] - Musculoskeletal Diseases [C05]
 
 

Download Options